Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 2013

View Archived Issues

Role for cannabinoid CB2 receptor signaling in Huntington's disease

MCT 1 linked to 3-bromopyruvate uptake and sensitivity in cancer cells

U.S. researchers present new vitamin D receptor ligands

Bristol-Myers Squibb prepares novel PDE10A inhibitors

University of Florida patents new interferon mimetic peptides

Alnylam Pharmaceuticals divulges new siRNAs

Nihon Medi-Physics presents new Alzheimer's disease diagnostics

New alpha7 nAChR positive allosteric modulators synthesized by Dainippon Sumitomo Pharma

Acorda Therapeutics reviews pipeline

Bristol-Myers Squibb studies BMS-986020 for IPF in phase II trial

Dainippon Sumitomo Pharma seeks Japanese approval for Meropen dosage

Amunix enters into licensing agreement with Janssen Biotech

FDA issues complete response letter for Rytary NDA

Novartis receives positive CHMP opinion for Ilaris in acute gouty arthritis

Results from a semiqualitative validation of [18F]-NAV-4694 imaging

Eisai begins recruiting patients in phase II study of Alzheimer's disease treatment candidate

Tresiba and Ryzodeg approved for diabetes in Europe

Array BioPharma presents update on ongoing projects

CSL Behring enrolls first patient in global phase III pediatric study of rIX-FP

Global phase I study of AZD-1208 commences

Translation research centers establish drug discovery and development alliance

BioCad advances development of Extimia for neutropenia

Second milestone achieved in Genfit's metabolic disorder collaboration with Sanofi

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...